- Patent Title: Benzazepine derivatives for the treatment of neurological disorders
-
Application No.: US10539385Application Date: 2003-12-18
-
Publication No.: US07696193B2Publication Date: 2010-04-13
- Inventor: Sanjeet Singh Sehmi , David Matthew Wilson , Jason Witherington
- Applicant: Sanjeet Singh Sehmi , David Matthew Wilson , Jason Witherington
- Applicant Address: GB Greenford, Middlesex
- Assignee: Glaxo Group Limited
- Current Assignee: Glaxo Group Limited
- Current Assignee Address: GB Greenford, Middlesex
- Agent Duke M. Fitch; Kathryn L. Sieburth; Lorraine B. Ling
- Priority: GB0229820 20021220; GB0312607 20030602
- International Application: PCT/EP03/14556 WO 20031218
- International Announcement: WO2004/056369 WO 20040708
- Main IPC: A61P7/00
- IPC: A61P7/00 ; A61K31/55 ; C07D223/16
Abstract:
The present invention relates to benzazepine derivatives of formula (I) wherein: R1 represents —C3-7 cycloalkyl optionally substituted by C1-3 alkyl; having pharmacological activity, processes for their preparation, to compositions containing them and to their use in the treatment of neurological and psychiatric disorders.
Public/Granted literature
- US20060040918A1 Benzo d!azepine derivatives for the treatment of neurological disorders Public/Granted day:2006-02-23
Information query
